“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals” (2022) Journal of Pharmaceutical Negative Results, pp. 921–929. doi:10.47750/pnr.2022.13.S09.110.